International drug giant joins China's National New Drug Screening Center

two international pharmaceutical giants, Professor Tamas Buffett, former senior vice president of roche, and DrSimon Campbell, former senior vice president of global research and development at Pfizer
,was appointed as a member of the China National New Drug Screening Center's Scientific Advisory BoardSo far, theincludes eight members appointed by2005, and the National New Drug Screening Center's Science and Technology Advisory Board is currently composed of 10 well-known biomedical experts,venture capitalists and pharmaceutical management veteransReporters from the National Center for New Drug Screening and the Shanghai Institute of Drug Research of the Chinese Academy of Sciences learned that on January 16 this year, the editorial department of the Proceedings of the National Academy of Sciences disclosed the pioneering progress made by Chinese scientists in the field of treatment of type 2 diabetes, which attracted widespread attention at home and abroadThe study found the world's first non-peptide small molecule B-G protein conjugate receptor agonisant, one of the small molecular compounds codenamed Boc5, that could become a new therapy for diabetes and other metabolicdiseasesIn this context, a number of internationally renowned scientists have written to express their desire to participate in this "exciting" research projectProfessor Tamas Buffett and Dr Simon Campbell also offered to join the National Center for New Drug Screening research and were eventually hired Researcher Ding Jian, director of the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences, believes that the joining of the two experts will effectively expand the strategic vision of innovative drug research at the National Center for New Drug Screening, increase the experience of downstream development, promote the pace of foreign cooperation, enhance the ability of international competition, and give China a place in the world's pharmaceutical innovation Professor Tamas Buffett is hungarian-American who has led the development of several innovative drugs of global influence and is now a member of the Hungarian Academy of Sciences and a fellow of the European Academy of Sciences Dr Simon Campbell, a British national, as the main organiser, led the development of innovative drugs such as polysaccharide , phenyl-aminochlorpine and cydofen, and was elected a Fellow of the British Academy of Medicine
200
2
00 (
Xinhua Provides without permission, is strictly prohibited from reprinting)